Home/Filings/4/0001213900-21-038634
4//SEC Filing

Townsend John 4

Accession 0001213900-21-038634

CIK 0001766140other

Filed

Jul 25, 8:00 PM ET

Accepted

Jul 26, 4:15 PM ET

Size

5.2 KB

Accession

0001213900-21-038634

Insider Transaction Report

Form 4
Period: 2021-07-15
Townsend John
Chief Financial Officer
Transactions
  • Award

    Stock Options

    2021-07-15+18,60541,861 total
    Exercise: $5.00Exp: 2031-07-15Common Stock (18,605 underlying)
Footnotes (1)
  • [F1]The stock options vest equally over a period of three years from the date of grant.

Issuer

Unicycive Therapeutics, Inc.

CIK 0001766140

Entity typeother

Related Parties

1
  • filerCIK 0001511906

Filing Metadata

Form type
4
Filed
Jul 25, 8:00 PM ET
Accepted
Jul 26, 4:15 PM ET
Size
5.2 KB